Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues

NCT03204396 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Glucagon-like Peptide-1
Smoking Cessation
Weight Change, Body
Craving

Interventions

DRUG: Dulaglutide
DRUG: 0.5 ml normal saline (0.9% sodium chloride [0.9% NaCl])

Sponsor

University Hospital, Basel, Switzerland